Role of Antithrombin III and Tissue Factor Pathway in the Pathogenesis of Sepsis
- PMID: 32172812
- DOI: 10.1016/j.ccc.2019.12.002
Role of Antithrombin III and Tissue Factor Pathway in the Pathogenesis of Sepsis
Abstract
The pathobiology of the septic process includes a complex interrelationship between inflammation and the coagulations system. Antithrombin (AT) and tissue factor are important components of the coagulation system and have potential roles in the production and amplification of sepsis. Sepsis is associated with a decrease in AT levels, and low levels are also associated with the development of multiple organ failure and death. Treatment strategies incorporating AT replacement therapy in sepsis and septic shock have not resulted in an improvement in survival or reversal of disseminated intravascular coagulation.
Keywords: Antithrombin; Coagulopathy; Multiple organ failure; Sepsis; Tissue factor.
Copyright © 2019 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure The authors have no significant relationships to disclose related to this article.
Similar articles
-
Activation of the extrinsic coagulation pathway in patients with severe sepsis and septic shock.Crit Care Med. 1998 Dec;26(12):2005-9. doi: 10.1097/00003246-199812000-00030. Crit Care Med. 1998. PMID: 9875912
-
Factor VIIa and antithrombin III activity during severe sepsis and septic shock in neutropenic patients.Blood. 1996 Aug 1;88(3):881-6. Blood. 1996. PMID: 8704245
-
[Are there certified indications for the use of antithrombin III in intensive care].Anasthesiol Intensivmed Notfallmed Schmerzther. 2001 Mar;36(3):143-53. doi: 10.1055/s-2001-11815. Anasthesiol Intensivmed Notfallmed Schmerzther. 2001. PMID: 11324345 Review. German.
-
Controlled trial of antithrombin III supplementation in fulminant hepatic failure.J Hepatol. 1993 Mar;17(3):326-31. doi: 10.1016/s0168-8278(05)80213-2. J Hepatol. 1993. PMID: 8315261 Clinical Trial.
-
Role of the tissue factor pathway in the pathogenesis and management of multiple organ failure.Blood Coagul Fibrinolysis. 2004 May;15 Suppl 1:S11-20. doi: 10.1097/00001721-200405001-00003. Blood Coagul Fibrinolysis. 2004. PMID: 15166928 Review.
Cited by
-
Urinary microRNAs in sepsis function as a novel prognostic marker.Exp Ther Med. 2023 May 26;26(1):346. doi: 10.3892/etm.2023.12045. eCollection 2023 Jul. Exp Ther Med. 2023. PMID: 37383369 Free PMC article.
-
Interleukin IL-5 alleviates sepsis-induced acute lung injury by regulating the immune response in rats.Bioengineered. 2021 Dec;12(1):2132-2139. doi: 10.1080/21655979.2021.1930746. Bioengineered. 2021. PMID: 34057015 Free PMC article.
-
Sepsis-Induced Coagulopathy: An Update on Pathophysiology, Biomarkers, and Current Guidelines.Life (Basel). 2023 Jan 28;13(2):350. doi: 10.3390/life13020350. Life (Basel). 2023. PMID: 36836706 Free PMC article. Review.
-
[COVID-19 and the kidneys-Clinical aspects].Nephrologe. 2021;16(1):26-32. doi: 10.1007/s11560-020-00470-2. Epub 2020 Dec 11. Nephrologe. 2021. PMID: 33343739 Free PMC article. Review. German.
-
Study of alteplase for respiratory failure in severe acute respiratory syndrome coronavirus 2/COVID-19: Study design of the phase IIa STARS trial.Res Pract Thromb Haemost. 2020 Aug 19;4(6):984-996. doi: 10.1002/rth2.12395. eCollection 2020 Aug. Res Pract Thromb Haemost. 2020. PMID: 32838109 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical